摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-n-heptyloxysalicylic acid | 127941-90-6

中文名称
——
中文别名
——
英文名称
4-n-heptyloxysalicylic acid
英文别名
heptyloxy 4 salicylic acid;4-(Heptyloxy)-2-hydroxybenzoic acid;4-heptoxy-2-hydroxybenzoic acid
4-n-heptyloxysalicylic acid化学式
CAS
127941-90-6
化学式
C14H20O4
mdl
——
分子量
252.31
InChiKey
GFOUVESKDMJIJA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    18
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    在包含具有2-辛氧基尾巴的棒状外消旋联苯介晶的简单二元混合物系统中观察到宽蓝相范围†
    摘要:
    容易制备四个具有2-辛氧基尾和在苯环的内核位置具有不同取代基的简单和棒状外消旋联苯介晶。这些外消旋联苯液晶元的中间相通过可变温度XRD和POM的特征结构得到证实。通常,在加热和冷却过程中,将适当比例的手性添加剂S811或ISO(6OBA)2添加到这些外消旋联苯液晶元中,可以诱发立方BP 。有趣的是,BPIII(5–6 K)在高手性条件下很容易控制由单取代联苯液晶元和手性掺杂剂S811组成的混合混合物。另外,当化合物C 6 OBiPhI-OH与35 wt%S811在冷却过程中混合时,BPIII的形成温度接近室温(36°C)。混合体系中存在的20 K以上的稳定BP由手性掺杂剂ISO(6OBA)2组成,没有取代的联苯液晶元C n OBiPhI-H或二氟取代的C n OBiPhI-FF。值得注意的是,通过在联苯化合物C 6 OBiPhI-H中仅添加10 wt%具有高HTP的手性掺杂剂ISO(6OB
    DOI:
    10.1039/c6ra20799e
点击查看最新优质反应信息

文献信息

  • Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds
    申请人:RICHARD Herve
    公开号:US20090285868A1
    公开(公告)日:2009-11-19
    Photostable UV-photoprotecting cosmetic sunscreen compositions contain (a) an effective UV-photoprotecting amount of at least one dibenzoylmethane compound sunscreen, (b) an effective radiation-photostablizing amount of at least one pyrrolidinone compound having the formula (I) below: and, advantageously, at least one liquid fatty phase and at least one lipophilic active sunscreen agent of low solubility, formulated into (c) a cosmetically acceptable support therefor.
    Photostable UV-防晒化妆品防晒组合物包含(a) 至少一种二苯甲酮类化合物防晒剂的有效UV-防晒量,(b) 至少一种具有以下公式(I)的吡咯烷酮化合物的有效辐射光稳定量:而且,有利的是,至少一种液态脂相和至少一种低溶解度的亲脂性活性防晒剂,配制成(c) 用于美容的可接受支持。
  • Chemical enhancer and method
    申请人:L'OREAL S.A.
    公开号:US20040162272A1
    公开(公告)日:2004-08-19
    The present invention relates to compositions containing at least one salicylic acid derivative and at least one cosmetic, dermatologic, pharmaceutical, etc. active agent, where the salicylic acid derivative increases, enhances, etc., the efficacy of the active agent, as well as to methods of making and using such compositions. The invention further relates to a method for enhancing the efficacy of active agents with these salicylic acid derivatives.
    本发明涉及含有至少一种水杨酸衍生物和至少一种化妆品、皮肤科、药物等活性剂的组合物,其中水杨酸衍生物增强、增强等活性剂的功效,以及制备和使用这种组合物的方法。本发明还涉及一种利用这些水杨酸衍生物增强活性剂功效的方法。
  • Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions
    申请人:Richard Hervé
    公开号:US20100143276A1
    公开(公告)日:2010-06-10
    Stable UV-screening cosmetic compositions contain at least one ester solvent derived from 4-carboxy-2-pyrrolidinone, of formula (I): in which: R 1 is a linear or branched C 1 -C 20 alkyl radical, and R 2 is a linear or branched C 1 -C 20 alkyl radical optionally containing a C 5 -C 6 ring member, the phenyl radical, the benzyl radical or the phenethyl radical, and at least one liquid fatty phase and at least one lipophilic UV-screening active agent, the at least one ester derivative constituting a solvent for the at least one active agent in the at least one liquid fatty phase and/or constituting an agent for improving the solubility of the at least one active agent in the at least one fatty phase.
    稳定的紫外线防护化妆品组合物包含至少一种来自4-羧基-2-吡咯烷酮衍生的酯类溶剂,其化学式为(I):其中:R1是线性或支链烷基,其碳数范围为C1-C20;R2是线性或支链烷基,可选含有C5-C6环成员、苯基、苄基或苯乙基,且其碳数范围为C1-C20;至少含有一种液态脂肪相和至少一种亲脂性紫外线防护活性剂,至少一种酯类衍生物在至少一种液态脂肪相中构成至少一种活性剂的溶剂和/或构成至少一种改善至少一种活性剂在至少一种脂肪相中溶解度的剂。
  • USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT
    申请人:Muller Benoit
    公开号:US20120269746A1
    公开(公告)日:2012-10-25
    The present invention relates to the use of at least one caprolactam derivative of formula (I) below: in which: n=0 or 1; m=0 or 1; p=0 to 13; R 1 is a linear or branched alkyl radical comprising a number t of carbon atoms of from 1 to 20; subject to the following conditions: (i) when p=0, m=0, (ii) when p=1 and n=1, m=1, (iii) when p=1 and n=0, m=0 and R 1 denotes a C 2 -C 20 alkyl radical; with the proviso that the sum of p+t is between 3 and 20, in a composition comprising, in a cosmetically acceptable medium, at least one liquid fatty phase and at least one lipophilic active agent, and containing no dibenzoylmethane-type UV screening agent, as a solvent for said active agent in said liquid fatty phase and/or as an agent improving the solubility of said active agent in the solid fatty phase. The present invention also relates to a composition comprising, in a cosmetically acceptable medium, at least one liquid fatty phase, characterized in that it comprises at least one caprolactam derivative of formula (I) as defined above and in that it does not contain a dibenzoylmethane-type UV screening agent.
    本发明涉及使用以下式(I)的至少一种己内酰胺衍生物:其中:n=0或1;m=0或1;p=0到13;R1是包含1到20个碳原子的线性或支链烷基,满足以下条件:(i)当p=0,m=0时,(ii)当p=1且n=1,m=1时,(iii)当p=1且n=0,m=0且R1表示C2-C20烷基;但p+t的总和在3到20之间,在包含至少一种液态脂肪相和至少一种亲脂性活性剂的化妆品可接受介质中,作为所述活性剂在所述液态脂肪相中的溶剂和/或作为改善所述活性剂在固态脂肪相中的溶解度的剂量。本发明还涉及一种化妆品可接受介质中含有至少一种液态脂肪相的组成物,其特征在于它包含上述定义的至少一种式(I)的己内酰胺衍生物,且不含二苯甲酮型紫外线筛选剂。
  • USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT
    申请人:Muller Benoit
    公开号:US20120282197A1
    公开(公告)日:2012-11-08
    The present invention relates to the use of at least one piperidine ester derivative of formula (I) below: in which: R 1 is a linear or branched C 1 -C 12 alkyl radical, R 2 is a linear or branched C 1 -C 20 alkyl radical, with the proviso that the sum of the carbon atoms for R 1 and R 2 is between 2 and 22, in a composition comprising, in a cosmetically acceptable medium, at least one liquid fatty phase and at least one lipophilic active agent, and containing no dibenzoylmethane-type UV screening agent, as a solvent for said active agent in said liquid fatty phase and/or as an agent improving the solubility of said active agent in said fatty phase. The present invention also relates to a composition comprising, in a cosmetically acceptable medium, at least one liquid fatty phase, characterized in that it comprises at least one piperidine ester derivative of formula (I) as defined above and in that it does not contain a dibenzoylmethane-type UV screening agent.
    本发明涉及使用公式(I)中至少一种哌啶酯衍生物: 其中:R1是直链或支链C1-C12烷基基团,R2是直链或支链C1-C20烷基基团,但R1和R2的碳原子总和在2到22之间,作为一种溶剂用于至少一种脂溶性活性剂在至少一种液态脂肪相中,且不含二苯甲酰甲烷类型的紫外线筛选剂。本发明还涉及一种组合物,其中至少包含一种液态脂肪相,在化妆品可接受的介质中,其特征在于其包含上述公式(I)中的至少一种哌啶酯衍生物,并且不含二苯甲酰甲烷类型的紫外线筛选剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐